Pentoxifylline for Children with Cerebral Malaria
Author Information
Author(s): Lell Bertrand, Köhler Carsten, Wamola Betty, Olola Christopher HO, Kivaya Esther, Kokwaro Gilbert, Wypij David, Mithwani Sadik, Taylor Terrie E, Kremsner Peter G, Newton Charles RJC
Primary Institution: KEMRI Centre for Geographic Medicine Research (Coast), Kilifi, Kenya
Hypothesis
Does pentoxifylline improve outcomes in children with cerebral malaria?
Conclusion
The study found a high mortality rate in the PTX group, but the small sample size limits definitive conclusions.
Supporting Evidence
- One child in the control group died, compared to four in the PTX group.
- TNF levels were lower in children receiving PTX.
- The study was stopped early due to safety concerns.
Takeaway
This study looked at a medicine called pentoxifylline to see if it helps kids with a serious type of malaria, but the results were mixed.
Methodology
Ten children received pentoxifylline while five received normal saline; outcomes were compared.
Potential Biases
The study was not randomized, which may introduce bias.
Limitations
The small sample size and early termination of the study limit the ability to draw strong conclusions.
Participant Demographics
Children aged 9 months to 8 years with cerebral malaria.
Statistical Information
P-Value
0.60
Statistical Significance
p = 0.60
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website